PROTTER, ANDREW A.,RICHER, JENNIFER,COCHRANE, DAWN
申请号：
EP12846720
公开号：
EP2739153A4
申请日:
2012.07.27
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
This disclosure describes the use of one or more compounds that fall within the scope of one or more structural formula I, II, III, IV, V, or VI for treating triple negative breast cancer. Compounds useful for treating breast cancer include those compounds of formulae I, II, III, IV, V, or VI that inhibit proliferation of breast cancer cells and/or lead to the death of breast cancer cells, especially triple negative breast cancer.
